Literature DB >> 25195016

Inflammation imaging of atherosclerosis in Apo-E-deficient mice using a (99m)Tc-labeled dual-domain cytokine ligand.

Zhonglin Liu1, Lilach O Lerman2, Hui Tang2, Christy Barber3, Li Wan3, Mizhou M Hui4, Lars R Furenlid3, James M Woolfenden3.   

Abstract

UNLABELLED: Interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) play a critical role in initiating and accelerating atherosclerosis. This study evaluated the imaging properties of (99m)Tc-TNFR2-Fc-IL-1RA ((99m)Tc-TFI), a dual-domain cytokine radioligand that targets TNF-α and IL-1β pathways, in assessing atherosclerosis development in apolipoprotein-E-deficient (ApoE(-)(/)(-)) mice.
METHODS: The feasibility and specificity of detecting atherosclerosis with (99m)Tc-TFI SPECT imaging were investigated in ApoE(-)(/)(-) and ApoE(+)(/)(+) mice. Fifty-four ApoE(-)(/)(-) mice were fed either an atherogenic diet (AGD) or a normal diet (ND) beginning at 5 weeks of age. Eighteen Apo-E wild-type (ApoE(+)(/)(+)) mice were fed an ND. Two groups of ApoE(-)(/)(-) mice (n=12 each group) on AGD and ND were imaged three times with (99m)Tc-TFI and a high-resolution SPECT system at 20-25, 30-40, and 48-52 weeks to study the evolution of atherosclerotic plaque.
RESULTS: Focal radioactive accumulations in the aortic arch region were observed in the ApoE(-)(/)(-) mice (n=12) on AGD but not in the ApoE(+)(/)(+) mice on ND (n=10). Apo-E(-)(/)(-) mice on ND (n=11) exhibited lower radioactive uptake than ApoE(-)(/)(-) mice on AGD (P<0.05). Co-injection of an excess of cold ligand with (99m)Tc-TFI resulted in significant reduction of (99m)Tc-TFI uptake in the ApoE(-)(/)(-) mice on AGD. Longitudinal studies showed that (99m)Tc-TFI uptake in the aortas of ApoE(-)(/)(-) mice progressively increased from 20 to 48 weeks. Real-time PCR assays demonstrated that atherosclerotic aortas expressed significantly higher IL-1β and TNF-α than the aortas from wild-type controls.
CONCLUSIONS: Atherosclerotic plaques were detected by (99m)Tc-TFI imaging in ApoE(-)(/)(-) mice. (99m)Tc-TFI is promising for specific detection of inflammatory response in atherosclerotic plaques.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apolipoprotein-E-deficient mice; Atherosclerosis; Inflammation; Interleukin-1; SPECT; Tumor necrosis factor

Mesh:

Substances:

Year:  2014        PMID: 25195016      PMCID: PMC4192104          DOI: 10.1016/j.nucmedbio.2014.08.004

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  26 in total

Review 1.  Innate and adaptive immunity in the pathogenesis of atherosclerosis.

Authors:  Göran K Hansson; Peter Libby; Uwe Schönbeck; Zhong-Qun Yan
Journal:  Circ Res       Date:  2002-08-23       Impact factor: 17.367

Review 2.  Role of biological agents in immune-mediated inflammatory diseases.

Authors:  Petros Efthimiou; Joseph A Markenson
Journal:  South Med J       Date:  2005-02       Impact factor: 0.954

Review 3.  Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions.

Authors:  J Vilcek; T H Lee
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

4.  SPECT imaging of inflammatory response in ischemic-reperfused rat hearts using a 99mTc-labeled dual-domain cytokine ligand.

Authors:  Zhonglin Liu; Christy Barber; Li Wan; Shan Liu; Mizhou M Hui; Lars R Furenlid; Hua Xu; James M Woolfenden
Journal:  J Nucl Med       Date:  2013-10-31       Impact factor: 10.057

5.  Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function.

Authors:  B S Cain; D R Meldrum; C A Dinarello; X Meng; K S Joo; A Banerjee; A H Harken
Journal:  Crit Care Med       Date:  1999-07       Impact factor: 7.598

6.  Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis.

Authors:  A M Bendele; E S Chlipala; J Scherrer; J Frazier; G Sennello; W J Rich; C K Edwards
Journal:  Arthritis Rheum       Date:  2000-12

Review 7.  TNF receptor subtype signalling: differences and cellular consequences.

Authors:  David J MacEwan
Journal:  Cell Signal       Date:  2002-06       Impact factor: 4.315

8.  TNF-alpha enhances cardiac myocyte NO production through MAP kinase-mediated NF-kappaB activation.

Authors:  H Kan; Z Xie; M S Finkel
Journal:  Am J Physiol       Date:  1999-10

Review 9.  Soluble cytokine receptors in biological therapy.

Authors:  Rafael Fernandez-Botran; Fabian A Crespo; Xichun Sun
Journal:  Expert Opin Biol Ther       Date:  2002-08       Impact factor: 4.388

10.  Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo.

Authors:  K J Van Zee; T Kohno; E Fischer; C S Rock; L L Moldawer; S F Lowry
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

View more
  3 in total

1.  Detection of atherosclerotic plaques in ApoE-deficient mice using (99m)Tc-duramycin.

Authors:  Zhonglin Liu; Brandon T Larsen; Lilach O Lerman; Brian D Gray; Christy Barber; Ahmad F Hedayat; Ming Zhao; Lars R Furenlid; Koon Y Pak; James M Woolfenden
Journal:  Nucl Med Biol       Date:  2016-05-19       Impact factor: 2.408

2.  Phenotypic transformation of intimal and adventitial lymphatics in atherosclerosis: a regulatory role for soluble VEGF receptor 2.

Authors:  Mahdi Taher; Shintaro Nakao; Souska Zandi; Mark I Melhorn; K C Hayes; Ali Hafezi-Moghadam
Journal:  FASEB J       Date:  2016-03-22       Impact factor: 5.191

Review 3.  IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus.

Authors:  Concepción Peiró; Óscar Lorenzo; Raffaele Carraro; Carlos F Sánchez-Ferrer
Journal:  Front Pharmacol       Date:  2017-06-13       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.